Education and empowerment would provide more equal access to careElla Balasa says she owes her life to the experimental phage therapy she was able access in no Share XEducation and empowerment would provide more equal access to carehttps://pharmaphorum.com/views-analysis-patients/education-and-empowerment-would-provide-more-equal-access-to-care/
Celebrations as NHS England agrees deal for Vertex’ cystic fibrosis tripleNHS England has agreed a deal with Vertex for its three-drug cystic fibrosis therapy Kaftrio, just days after Share XCelebrations as NHS England agrees deal for Vertex’ cystic fibrosis triplehttps://pharmaphorum.com/news/celebrations-as-nhs-england-agrees-deal-for-vertex-cystic-fibrosis-triple/
As CHMP backs Vertex’ CF triple, campaigners plead for speedy UK dealCystic fibrosis patient groups in the UK are celebrating a recommendation by the EMA’s human medicines committee to Share XAs CHMP backs Vertex’ CF triple, campaigners plead for speedy UK dealhttps://pharmaphorum.com/news/as-chmp-backs-vertex-cf-triple-campaigners-plead-for-speedy-uk-deal/
Shares in Vertex jump on overnight success of CF triple therapyShares in US pharma Vertex were up sharply in premarket trading after its newly-launched cystic fibrosis triple therapy attained blockbuster status Share XShares in Vertex jump on overnight success of CF triple therapyhttps://pharmaphorum.com/news/shares-in-vertex-jump-on-overnight-success-of-cf-triple-therapy/
